Share Name Share Symbol Market Type Share ISIN Share Description
Aviva Plc LSE:AV. London Ordinary Share GB0002162385 ORD 25P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 273.30 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
273.60 273.80
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Life Insurance 31,243.00 3,933.00 63.80 4.3 10,735
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 273.30 GBX

Aviva (AV.) Latest News

More Aviva News
Aviva Investors    Aviva Takeover Rumours

Aviva (AV.) Discussions and Chat

Aviva Forums and Chat

Date Time Title Posts
22/10/202018:09AVIVA PLC 4,794
12/10/202009:41AVIVA (MODERATED)46
12/4/201907:49Aviva SLa Lgen??1
21/2/201908:08Aviva volatility173

Add a New Thread

Aviva (AV.) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-10-22 15:20:17273.803681,007.58AT
2020-10-22 15:20:17273.801,4573,989.27AT
2020-10-22 15:20:17273.801,7224,714.84AT
2020-10-22 15:20:17273.801,8004,928.40AT
2020-10-22 15:20:17273.801,5854,339.73AT
View all Aviva trades in real-time

Aviva (AV.) Top Chat Posts

Aviva Daily Update: Aviva Plc is listed in the Life Insurance sector of the London Stock Exchange with ticker AV.. The last closing price for Aviva was 273.30p.
Aviva Plc has a 4 week average price of 270p and a 12 week average price of 260.90p.
The 1 year high share price is 439.40p while the 1 year low share price is currently 205.70p.
There are currently 3,927,742,582 shares in issue and the average daily traded volume is 7,533,855 shares. The market capitalisation of Aviva Plc is £10,734,520,476.61.
pol123: AB will need to pull her finger out and unlock value quicker. AVs share price performance continues to slip. Expected AV to be well North of £3 by now. Divi news + disposal news + roadmap to growth. The more the share price falls the less they will pay in divi on a yield basis At what point do we become a target for asset strippers...
spud: Here’s why I think the Aviva share price could be set to double Alan Oscroft | Wednesday, 30th September, 2020 Insurance company shares tend to be more volatile than the FTSE 100. Both in times of exuberance and in times of gloom. Aviva (LSE: AV) is a good example. The Aviva share price has fallen 32% in 2020, compared to a 22% drop for the index. The shares are only around 286p now, after starting the year above 420p. Prior to the arrival of the Covid-19 pandemic, Aviva was already struggling a little. Investors weren’t too happy with the lack of impetus from top management. They just seemed to be happy muddling along and paying dividends. But the rest of the industry was working towards greater efficiency following on from the financial crisis. As an Aviva shareholder, I didn’t object too strenuously to taking the dividends. But the Aviva share price performance hasn’t impressed me much. It was lagging the Footsie even before the 2020 crash. Some of the cash being handed out as dividends could surely be put to better use, aiming for longer-term gains. New chief executive Amid the pandemic chaos of 2020, we’ve seen some very positive moves from Aviva. And you might have missed their importance while seeking to avoid the depressed sector altogether. The key move was the appointment of Amanda Blanc as new CEO in July. As my Motley Fool colleague G A Chester has suggested, her rapid investment of £1m in Aviva shares was a big vote of confidence. At today’s Aviva share price, she’s down a little, but I think she’ll do well from those shares over the long term. Under Blanc’s leadership, Aviva has already moved to sell off a majority stake in Aviva Singapore. The sale, to a consortium led by Singapore Life Ltd, is expected to conclude by January 2021. It will raise £1.6bn, which will do some good for the balance sheet. More changes to come? I’m expecting more in the way of restructuring under the new boss. And there might be a short-term need to redirect capital. To that end, I wouldn’t be surprised to see the Aviva dividend rebased when it’s fully reinstated. Analysts currently forecast something close to the pre-pandemic levels and, on the current Aviva share price, they suggest yields of 9-10%. So there’s room for something less than that while still providing a decent yield. And, under a new boss is often the best timing for such changes. Even with a rebased dividend, I’d still see Aviva as one of the best buys on the FTSE 100 right now. We’re looking at forward P/E multiples way down in single digits. Forecasts suggest something between 5 and 5.5, which I think offers plenty of upside. The shares are trading at a hefty discount to net asset value too, which lends further support for a potential bullish resurgence. Can the Aviva share price double? Brexit is still weighing heavily on financial stocks, and I don’t expect them to get back to index-average P/E ratios of around 14 for a while. But something around 10 or 11 wouldn’t be stretching at all, in my view. I could easily see Aviva shares doubling in price over the next 12-24 months, and still looking like decent long-term value. spud
1robbob: I do have my tougue in my cheek here!!!!! Of course I fully understand the Maths...but I stand by my suggestion Traditional buy-backs through the market never work. Too small to make a lssting difference just a waste of shareholders cash ...and as you point out it is in the company's interest for the share price to keep falling whilst buying back the shares!!!! short the shares to the Company and buy them back later. No thanks If France alone is going to realise circa 25% plus of our Market Capitalisation One would have thaught that the potential buyers might think of buying the entire Company Offering to Buy-back by Tender 20%-25% of the equity that would make a difference !!. Perversely the share price would rise and almost certainly insufficient stock would be tendered...perhaps!! but the price momentum would have been established AB really does have to think outside the box to bring about a lasting change in the markets' view of Aviva
1robbob: I would reiterate an earlier post of mine When the asset sales are complete, if the share price has failed to recover, I do think that AB should consider a Tender Offer to buy back shares at around 400p (ie significantly higher than the share price but lower than the asset value per share) .....But definitely not a market share buy-back programme which only rewards short sellers and is proven to have no effect in improving the share price
spud: Aviva, out of the ashes BUY IC Tip: Buy at 292p Aviva (AV.), its marketing literature claims, is there to help its 33m customers “defy uncertainty”. But the insurance giant’s share price pays little heed to that mantra. In each of the past five years, the stock has underperformed the FTSE All-Share, trailing the index by an average of 10 per cent. The last time it did beat the broader market in 2015 it underperformed peers by 5 per cent. And on that score the stock is again adrift of its sector this year, according to financial data provider FactSet. Matters haven't been helped by boardroom churn. When Amanda Blanc took over in July, she became Aviva’s fourth new chief executive in eight years. And though her predecessor Maurice Tulloch was forced to step down for family health reasons, the turnover rate has hardly given the impression of a clear, consistent and long-term view from the top. That's unfortunate; insurance, after all, involves balancing assets and liabilities over decades. A lack of management consistency has compounded the group’s notorious complexity. As well as being the UK’s largest life insurer, Aviva is a big player in general insurance, pensions and asset management. Operations across Europe, Asia and Canada might sound like canny geographical diversification, but are often cited as evidence of a sprawling, unfocused and unwieldy model. But investors are arguably most concerned about Aviva’s core business, and the challenge of matching long-term liabilities to reliable assets when the return on many government bonds is zero or even negative. Little wonder, given these issues, that the shares’ valuation metrics – which include a near-record discount to book value, a double-digit forecast dividend yield and a single-digit price/earnings ratio – all scream ‘avoid’. Things can only get better? Despite this, we struggle to see how the stock falls further from here. Between a strong capital base, Ms Blanc’s encouraging early actions, a good underlying brand and what could soon be the market’s recognition of businesses with resilient cash generation, investors’ hopes for share price outperformance no longer look fanciful. Analysts appear to agree. Although Aviva shares have failed to breech the City’s 12-month average price target since March 2017, no brokerage or bank has had the insurer on a ‘sell’ rating for two years. This may not surprise, what with most equity research being written to market shares to clients, but we would nevertheless expect to see at least one bear across the 18 firms covering the stock given the track record. The fact that no analyst believes the shares are worth less than 300p also points to a consensus that the downside may finally be priced in. After a long decline, average earnings forecasts for 2020 and 2021 also recently bounced, having dropped to lows of 46.8p and 54.2p, respectively, over the summer. It’s hard to separate this from the confident and clear message from Ms Blanc, who before re-joining Aviva held executive roles at rivals Zurich and AXA and served as the first woman chair of the Association of British Insurers. “From this moment on, we must deliver,” she said at Aviva’s interim results on 6 August. “Nothing else will do. My focus is making sure it happens and at pace." So far, this has been backed up by actions. First, the board announced a 6p-a-share second interim dividend for 2019, having cut the final 21.4p distribution in April amid pressure from the Prudential Regulation Authority. In the end, capital, cash-generation and the group’s operational performance all proved stronger or more resilient than expected. With an eye on reducing leverage in the business, shareholders have been promised an update on the payout policy for later this year. But in short dividends are back. Second, the new chief executive has already made a big move to right-size the group. Earlier this month, Aviva agreed to sell a majority stake in its Singapore division, making good on a pledge to focus on the UK, Ireland and Canada, where Ms Blanc believes the franchises are strongest. Under the terms of the deal, Aviva will receive SGD2bn (£1.2bn) in cash, SGD250m in vendor finance notes, and keep a 25 per cent stake in a newly created group that combines Aviva’s fast-growing legacy operation with rival Singlife. The proceeds will be used to boost dividends and reduce debt, but at almost two times the division’s net asset value, the transaction is above all proof that Aviva can extract good prices for its international divisions if it can find the right buyers. Surplus capital of almost double regulatory requirements also means the group is in no rush to sell, either, should it choose to exit its vastly reduced Asian business or life insurance operations in France, Italy and Poland. Showing her belief in the strategy, Ms Blanc immediately followed the disposal by purchasing £1m-worth of stock in the insurer at 307.8p a share – an outlay equivalent to a little more than her predecessor’s annual basic salary in 2019, before tax. That personal investment carries with it other sources of conviction. For a start, Aviva still made a lot of money in the first half of 2020: were it not for £165m of one-off general insurance claims stemming from the pandemic, the group’s operating profit would have been flat year on year. This resilience was in part due to higher-margin bulk-purchase annuity agreements in the UK Life division, where profits grew 9 per cent and look set to maintain their positive momentum. That pre-tax profit dropped by nearly a third to £1.1bn was due to asset value losses in the period, as well as downgrades in the long-term return assumptions of equities and property – which for a company so heavily invested in the markets is hardly a surprise. It’s worth reiterating that after all of these hits, the group was still profitable. A decision not to remit cash from subsidiaries to the group level, justified by the acute uncertainty in the first half and regulatory guidance, meant ‘centre liquidity’ – the best proxy to a cash pile – stayed broadly flat at £2.5bn. Prior to Covid-19, this was rising despite the payment of £3.4bn in ordinary dividends between 2017 and 2019. In backing the business with her own money, Ms Blanc knows that Aviva’s long-term liability-matching is more resilient than the market gives it credit for. Not only do the government and corporate bonds the insurer buys carry high credit ratings with low risk of default, but its portfolio is well-diversified. It is largely immune to a sudden widening in credit spreads, too, given that bonds are normally held to maturity. To analysts at RBC, Solvency II rules also mean “that lower interest rates have little impact on capital surpluses”, even if they do result in a reduction in ratios. We would also point out that this debt-buying is prevalent across other large European life insurers such as Allianz and Zurich Insurance, neither of which trade at a discount to book value. IC View Is Aviva a value trap? The track record since we tipped the company in 2018 at just under 500p would suggest so. But the group’s cash generation, shareholder equity and net premium growth over that time is atypical of a company whose market or earnings potential is vanishing. As such, we think both dividend hunters and classic value investors ought to take another look at the bull case. spud
1robbob: I am interested in your views on share buy backs? Personaly I am dead against what has become the norm in buying back shares. That being through purchases in the market. All this does is allow traders to short-sell and buy back same day Although it reduces the number of shares, reduces div costs and helps eps rarely results in an improved share price What would happen if a Company offered to buy back shares by a Tender Offer at a premium to the current share price???? Say Aviva offered to buy back shares by Tender at say 400p? We would all sell to the Company at 400p...and most of us would buy back through the market at somewhere between 280p and 400p Now that would improve the share price
spud: Shares in insurance companies are holding firm despite a high court ruling this month that they could have to pay out thousands. In the judgement, the court ruled that some insurers would have to pay out to businesses claiming business interruption due to the pandemic. However, as City AM reports, investors in Legal and General [LGEN], Aviva [AV] and Standard Life [SLA] “shook off the ruling”. What’s more remarkable is that many had predicted the insurance sector would be one of the hardest hit by the outbreak, paying out on both business and life insurance policies. Yet, while half-year profits have seen sharp falls, the sector seems resilient. Unlike banking, which has seen share prices suppressed since the outbreak, insurers have by and large managed to claw back some losses. So, what’s the outlook for heavyweights Legal and General, Aviva and Standard Life’s share prices for the rest of the year? Legal and General’s share price While Legal and General’s share price has been on a downward trajectory since mid-August, it's still lightyears above the 138.6p it was trading at on 23 March. Causing the late summer slip were first-half pre-tax profits of £285m, a steep 73% drop from the same period last year. Weighing on earnings were historically low-interest rates and payouts on life insurance policies, both due to the coronavirus. £285MILLION LEGAL & GENERAL'S HALF-YEAR PRE-TAX PROFITS - A 73% YOY DECLINE Still, that didn't stop Legal and General from paying out a 4.93p per share first-half dividend. While that's less than some analysts were expecting, considering that the regulator has been pressuring insurers to freeze payouts to shore up capital, it’s better than nothing. For income-seeking investors, some analysts reckon dividends will be back to strength sooner rather than later. Gordon Aitken, an analyst at RBC Capital Markets, said: “We see this dividend caution as merely temporary and not an indication that dividend growth will slow.” Among the analysts tracking the stock, Legal and General's share price carries a 288.79p price target, which would see a 59.6% upside on 21 September’s closing price if hit. “We see this dividend caution as merely temporary and not an indication that dividend growth will slow” - Gordon Aitken, RBC Capital Markets analyst Aviva’s share price Two months into the job and Aviva's new CEO Amanda Blanc has picked up £1m worth of the insurer's stock. Picking up 324,887 Aviva shares at just over 300p certainly shows self-belief in her own turnaround strategy. Having replaced Maurice Tulloch in the top spot after the former CEO resigned for family health reasons, Blanc has the task of turning around Aviva's share price, which has fallen 30% since the start of the year. 30% AVIVA'S YTD SHARE PRICE DROP To do this, Blanc has pledged to focus on Aviva’s core UK, Ireland and Canada markets, while reducing its European and Asian operations. Already Blanc has overseen the sale of Aviva's Singapore operations to Singapore Life for $1.98bn in one of the biggest insurance deals in Southeast Asia. “The sale of Aviva Singapore is a significant first step in our new strategy to bring greater focus to Aviva’s portfolio,” said Blanc. The deal also got the blessing from analysts at Jefferies, who described it as constituting “exceptional value creation” for Aviva, while commending Blanc for showing “decisive action”. So, a promising start from the new CEO, with the possibility of having picked up Aviva’s share price at a bargain? Analysts tracking the stock on Yahoo Finance have a 551.33p average price target. Hitting this would see an impressive 95.3% upside on Aviva’s current share price (as of 21 September’s close). “The sale of Aviva Singapore is a significant first step in our new strategy to bring greater focus to Aviva’s portfolio” - Aviva's new CEO Amanda Blanc Standard Life Aberdeen’s share price Like Aviva, Standard Life’s share price has seen a steep drop off since the start of the year, followed by a mild recovery since the start of the pandemic. In half-year results, adjusted pre-tax profit came in at £195m, down 30% from the £280m seen in the same period last year. The sharp downturn in profit can be notched up to both the coronavirus and the loss of its business with Lloyds bank. In total, net withdrawals came in at £24.8bn, causing fee revenue to drop 13%. Despite the losses, Standard Life rewarded shareholders with a 7.3p interim dividend. £195MILLION STANDARD LIFE'S HALF-YEAR PRE-TAX PROFITS - A 30% YOY DECLINE Presiding over his last set of results, the outgoing CEO Keith Skeoch commented that “the long-term consequences of the crisis will be profound,” and predicted that any economic recovery would be W-shaped without a vaccine. While that struck a gloomy chord, Standard Life actually saw overall outflows slow, excluding the withdrawal paid to Lloyds. If the asset manager continues to reduce outflows, Standard Life’s share price may have already been through the worst. Analysts have pinned a 380.07p average target on Standard Life’s share price, which would see a 75% gain on the current share price (through 21 September’s close). spud
oggyrocks: Think Aviva France is going to be sold sooner rather than later. There are several new articles in French business web sites in the last few days. There is nothing new, but the fact that it is in the French Press (rather than just being talked about here) is very promising. No smoke without fire. There could be an announcement any time soon (on AV France) and this should be another big boost for the share price Have a decent holding here. Need clarification on dividends for any major share price move I think. Added a few LGEN today as these have taken a bit of a dip recently.
1robbob: A little sloppyness in the share price may not be such a bad thing. It might convince AB that too large a dividend 'rebasing' could severely de-stabilise the share price
spud: A Fool article but worth a read: The Aviva share price has crashed 30% this year. Here’s why I’d buy today Stock Markets4 hours ago (Aug 18, 2020 07:10) This year, the Aviva (LSE: LON:AV) share price has crashed from 419p to 289p — a fall of 31%. Furthermore, it’s trading at a 48% discount to a high of 552p that it made little more than two years ago. Writing in the wake of the company’s recent half-year results, my Motley Fool colleague Cliff D’Arcy highlighted its cheap historic price-to-earnings ratio, and a dividend he felt “could easily triple or quadruple from here”. I agree that Aviva’s shares are cheap. But here I want to tell you about one thing that particularly impressed me on the day of the results. It’s a big factor in why I rate the shares a ‘long-term buy’ today. The Aviva share price jumped on its results The FTSE 100 dropped 1.3% on 6 August. By contrast, Aviva’s shares jumped 4.6% on the back of its results. The results themselves showed a resilient business in terms of both operating performance and financial strength. However, it was the performance of new chief executive Amanda Blanc — in place for just a month — that really fired me up about the future prospects for the business. I haven’t been as impressed by the first presentation of a new Footsie CEO since Dave Lewis debuted as the new Tesco (LON:TSCO) boss in 2014. Mont Blanc In the results release, but more particularly in her introductory presentation on the analyst conference call, I thought Blanc was cool, solid and thoroughly assured. She scored high marks from me for her razor-sharp identification of Aviva’s strengths and weaknesses, and for her clear, no-nonsense strategy for taking the business forward. She registered a correspondingly low score on what might be called the waffle-o-meter. There’s to be no protracted ‘strategic review’, which we often see from an incoming CEO. Blanc is simply going to get on with making the changes she’s identified as necessary for delivering value for shareholders. She worked for Aviva’s rivals for a large part of her career. I suspect she has a very good insight into the group’s formidable competitive advantages, and how to maintain them. Also, into the areas in which it’s not so strong, and how to improve them. Strategy Blanc laid out her strategy in relatively few words. Attempting to distil it even further, it’s as follows: Invest in its market-leading positions in the UK, Ireland and Canada for growth and superior shareholder returns. In Europe and Asia, invest if a market-leading position and superior returns are achievable. Otherwise, withdraw capital from what are decent businesses, but businesses for which there may ultimately be better owners than Aviva. Returning to the Aviva share price The company is reviewing its dividend policy, and will announce the outcome before the end of the year. In my view, it’s a question not of whether the dividend will be rebased, but the level to which it will be rebased for sustainable future growth. I expect the ordinary dividend to be fairly conservative, but with the prospect of special dividends or capital returns — to wit, proceeds from disposals of those businesses for which there may ultimately be better owners than Aviva. I think the Aviva share price barely gives credit for the business as it is, far less its prospects under Blanc’s strategy. It’s for this reason, I rate the shares a long-term buy. spud
Aviva share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201023 06:09:47